» Articles » PMID: 17558415

Multifunctional TH1 Cells Define a Correlate of Vaccine-mediated Protection Against Leishmania Major

Overview
Journal Nat Med
Date 2007 Jun 15
PMID 17558415
Citations 797
Authors
Affiliations
Soon will be listed here.
Abstract

CD4+ T cells have a crucial role in mediating protection against a variety of pathogens through production of specific cytokines. However, substantial heterogeneity in CD4+ T-cell cytokine responses has limited the ability to define an immune correlate of protection after vaccination. Here, using multiparameter flow cytometry to assess the immune responses after immunization, we show that the degree of protection against Leishmania major infection in mice is predicted by the frequency of CD4+ T cells simultaneously producing interferon-gamma, interleukin-2 and tumor necrosis factor. Notably, multifunctional effector cells generated by all vaccines tested are unique in their capacity to produce high amounts of interferon-gamma. These data show that the quality of a CD4+ T-cell cytokine response can be a crucial determinant in whether a vaccine is protective, and may provide a new and useful prospective immune correlate of protection for vaccines based on T-helper type 1 (TH1) cells.

Citing Articles

iDC-targeting PfCSP mRNA vaccine confers superior protection against Plasmodium compared to conventional mRNA.

Yanik S, Venkatesh V, Gordy J, Alameh M, Meza J, Li Y NPJ Vaccines. 2025; 10(1):34.

PMID: 39971939 PMC: 11840135. DOI: 10.1038/s41541-025-01089-x.


An LNP-mRNA vaccine modulates innate cell trafficking and promotes polyfunctional Th1 CD4 T cell responses to enhance BCG-induced protective immunity against Mycobacterium tuberculosis.

Lukeman H, Al-Wassiti H, Fabb S, Lim L, Wang T, Britton W EBioMedicine. 2025; 113:105599.

PMID: 39955975 PMC: 11871481. DOI: 10.1016/j.ebiom.2025.105599.


Immunogenicity and protective efficacy of a multi-antigenic adenovirus-based vaccine candidate against .

Yun J, Shin E, Lee Y, Lee J, Lee H, Kim J Front Microbiol. 2025; 16:1492268.

PMID: 39927262 PMC: 11802578. DOI: 10.3389/fmicb.2025.1492268.


Specific immune response to and ability to control mycobacterial replication are not impaired in subjects with immune-mediated inflammatory disease and tuberculosis infection.

Farroni C, Altera A, Salmi A, Vanini V, Cuzzi G, Arlehamn C Front Immunol. 2025; 15:1484143.

PMID: 39872515 PMC: 11770028. DOI: 10.3389/fimmu.2024.1484143.


Immunogenicity and vaccine efficacy of -derived extracellular vesicles as a novel vaccine candidate.

Park S, Kim Y, Lee H, Han J, Seo B, Park G Virulence. 2025; 16(1):2453818.

PMID: 39831520 PMC: 11749362. DOI: 10.1080/21505594.2025.2453818.